192 related articles for article (PubMed ID: 33398534)
1. Efficacy of clobazam as add-on therapy in brain tumor-related epilepsy.
Brahmbhatt N; Stupp R; Bushara O; Bachman E; Schuele SU; Templer JW
J Neurooncol; 2021 Jan; 151(2):287-293. PubMed ID: 33398534
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of artisanal preparations of cannabidiol for the treatment of epilepsy: Practical experiences in a tertiary medical center.
Porcari GS; Fu C; Doll ED; Carter EG; Carson RP
Epilepsy Behav; 2018 Mar; 80():240-246. PubMed ID: 29429908
[TBL] [Abstract][Full Text] [Related]
3. Stable dosages of clobazam for Lennox-Gastaut syndrome are associated with sustained drop-seizure and total-seizure improvements over 3 years.
Conry JA; Ng YT; Kernitsky L; Mitchell WG; Veidemanis R; Drummond R; Isojarvi J; Lee D; Paolicchi JM;
Epilepsia; 2014 Apr; 55(4):558-67. PubMed ID: 24580023
[TBL] [Abstract][Full Text] [Related]
4. CLB add-on treatment in patients with epileptic encephalopathy: a single center experience with long-term follow-up.
Türkdoğan D; Öztürk G
Acta Neurol Belg; 2022 Feb; 122(1):51-57. PubMed ID: 33782854
[TBL] [Abstract][Full Text] [Related]
5. Optimizing clobazam treatment in patients with Lennox-Gastaut syndrome.
Isojarvi J; Gidal BE; Chung S; Wechsler RT
Epilepsy Behav; 2018 Jan; 78():149-154. PubMed ID: 29202277
[TBL] [Abstract][Full Text] [Related]
6. Don't Fear the Reefer-Evidence Mounts for Plant-Based Cannabidiol as Treatment for Epilepsy.
Perry MS
Epilepsy Curr; 2019; 19(2):93-95. PubMed ID: 30955420
[TBL] [Abstract][Full Text] [Related]
7. Quality of life, mood and seizure control in patients with brain tumor related epilepsy treated with lacosamide as add-on therapy: A prospective explorative study with a historical control group.
Maschio M; Zarabla A; Maialetti A; Fabi A; Vidiri A; Villani V; Giannarelli D
Epilepsy Behav; 2017 Aug; 73():83-89. PubMed ID: 28623754
[TBL] [Abstract][Full Text] [Related]
8. Tolerability of clobazam as add-on therapy in patients aged 50 years and older with drug-resistant epilepsy.
Nagarajan E; Lynch TM; Frawley B; Bunch ME
Neurol Sci; 2023 Aug; 44(8):2883-2888. PubMed ID: 36964317
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the Effects of Clobazam on Seizure Control and Quality of Life in Children With Lennox-Gastaut Syndrome: A Pilot Study.
Weinstock A; Agarwal N; Farooq O; Cheema Z; Hamilton D; Parrish J
J Child Neurol; 2019 Jul; 34(8):432-439. PubMed ID: 30913948
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of cannabidiol in subjects with refractory epilepsy relative to concomitant use of clobazam.
Savage TE; Sourbron J; Bruno PL; Skirvin LA; Wolper ES; Anagnos CJ; Thiele EA
Epilepsy Res; 2020 Feb; 160():106263. PubMed ID: 31923763
[TBL] [Abstract][Full Text] [Related]
11. Clobazam in treatment of refractory epilepsy: the Canadian experience. A retrospective study. Canadian Clobazam Cooperative Group.
Epilepsia; 1991; 32(3):407-16. PubMed ID: 2044502
[TBL] [Abstract][Full Text] [Related]
12. NEOPLASM study: Real-life use of lacosamide in patients with brain tumor-related epilepsy.
Villanueva V; Saiz-Diaz R; Toledo M; Piera A; Mauri JA; Rodriguez-Uranga JJ; López-González FJ; Gómez-Ibáñez A; Garcés M; González de la Aleja J; Rodríguez-Osorio X; Palao-Duarte S; Castillo A; Bonet M; Ruiz-Giménez J; Palau J; Arcediano A; Toledo M; Gago A
Epilepsy Behav; 2016 Dec; 65():25-32. PubMed ID: 27863278
[TBL] [Abstract][Full Text] [Related]
13. Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation.
Wilby J; Kainth A; Hawkins N; Epstein D; McIntosh H; McDaid C; Mason A; Golder S; O'Meara S; Sculpher M; Drummond M; Forbes C
Health Technol Assess; 2005 Apr; 9(15):1-157, iii-iv. PubMed ID: 15842952
[TBL] [Abstract][Full Text] [Related]
14. Clinical and electrocorticographic response to antiepileptic drugs in patients treated with responsive stimulation.
Skarpaas TL; Tcheng TK; Morrell MJ
Epilepsy Behav; 2018 Jun; 83():192-200. PubMed ID: 29719278
[TBL] [Abstract][Full Text] [Related]
15. Real-world data on cannabidiol treatment of various epilepsy subtypes: A retrospective, multicenter study.
Kühne F; Becker LL; Bast T; Bertsche A; Borggraefe I; Boßelmann CM; Fahrbach J; Hertzberg C; Herz NA; Hirsch M; Holtkamp M; Janello C; Kluger GJ; Kurlemann G; Lerche H; Makridis KL; von Podewils F; Pringsheim M; Schubert-Bast S; Schulz J; Schulze-Bonhage A; Steinbart D; Steinhoff BJ; Strzelczyk A; Syrbe S; De Vries H; Wagner C; Wagner J; Wilken B; Prager C; Klotz KA; Kaindl AM
Epilepsia Open; 2023 Jun; 8(2):360-370. PubMed ID: 36693811
[TBL] [Abstract][Full Text] [Related]
16. Clobazam: effect on frequency of seizures and safety profile in different subgroups of children with epilepsy.
Klehm J; Thome-Souza S; Sánchez Fernández I; Bergin AM; Bolton J; Harini C; Kadish NE; Libenson M; Peters J; Poduri A; Rotenberg A; Takeoka M; Bourgeois B; Loddenkemper T
Pediatr Neurol; 2014 Jul; 51(1):60-6. PubMed ID: 24830765
[TBL] [Abstract][Full Text] [Related]
17. Intermittent clobazam prophylaxis in hot water epilepsy is safe and effective: a prospective study.
Satishchandra P; Dilipkumar S; Subbakrishna DK; Sinha S
Epilepsy Res; 2014 Sep; 108(7):1238-42. PubMed ID: 24929679
[TBL] [Abstract][Full Text] [Related]
18. The long-term efficacy of cannabidiol in the treatment of refractory epilepsy.
Patel S; Grinspoon R; Fleming B; Skirvin LA; Wade C; Wolper E; Bruno PL; Thiele EA
Epilepsia; 2021 Jul; 62(7):1594-1603. PubMed ID: 34050682
[TBL] [Abstract][Full Text] [Related]
19. Safety and Efficacy of Supratherapeutic Doses of Clobazam.
Gedela S; Freedman DA; Gedela S; Glynn P; Salvator A; Patel AD
J Child Neurol; 2019 Oct; 34(12):735-738. PubMed ID: 31215313
[TBL] [Abstract][Full Text] [Related]
20. [Effectiveness and role of lamotrigine in the paradigm shift towards new antiepileptic drugs: a therapeutic strategy proposed after an investigation of a large number of cases at a single hospital].
Yamamoto T; Yamazoe T; Fujimoto A; Kobayashi R; Yokota T; Okanishi T; Uchiyama G; Ohashi T; Tanaka T; Enoki H
Brain Nerve; 2014 Jan; 66(1):59-69. PubMed ID: 24371132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
